Bacterial evolution then and there and here and now

C. difficile genome shows it is still emerging as a health problem

Bacterial evolution then and there and here and now

Phylogenetic trees of C. difficile based on whole-genome sequences. Arrows and unfilled circles denote insertion and deletion events, respectively. Genomic islands carrying drug resistance genes are shown with asterisks. (A) Deep-branching phylogeny that illustrates the relationships between different lineages/ribotypes are shown by different colours. The four 027 ribotype isolates are collectively represented as node '027s'. Scale bar indicates number of substitutions per site. The root connects to C. bartlettii and C. hiranonis. (B) Split decomposition network indicating microevolution within the hypervirulent lineage. Strain names are coloured according to countries of isolation (blue, United States; red, United Kingdom; green, France). Bootstrap values are labelled along branches. The root connects to strain 630.

A study published today sheds new light on how Clostridium difficile (Cdiff) has emerged to cause disease in human populations. The team shows that, rather than evolving once as a disease-causing organism and spreading around the world, Cdiff has emerged as a pathogen many times and is likely to continue to do so.

The results raise the question of what is the driving force for the repeated emergence?

Cdiff becomes a healthcare threat after people have been treated with antibiotics, which disrupt the normal bugs in the gut. This allows their gut ecology to be overrun by resistant Cdiff, which produce toxins, leading to diarrhoea and gut damage. Cdiff survives and transmits easily through the bacterial family's trademark ability to produce infectious and highly resistant spores.

It was only in 1978 that the first reports of Cdiff infections were published: in the following 30 years, it has become a global problem, with different variants emerging at different times in different countries.

To study this emergence, the team generated whole genome sequences for eight diverse Cdiff isolates, taken from six countries and including human and bovine infections. The results show that Cdiff is highly diverse; two strains of Cdiff may differ by about 2.4 per cent - greater than the divergence between chimps and humans.

Cdiff is clearly an ancient species, millions of years old, but became a significant health problem to humans only three decades ago. However, the results show that epidemic and disease-causing variants occur on several branches of this diverse tree. Its rapid emergence as a pathogen may therefore be due to changes in the environment, such as human activity, use of antibiotics or healthcare practice.

Some strains, however, have spread very rapidly. An outbreak in Canada in 2003 spread to the UK and is now responsible for 50 per cent of cases in the UK. The challenge for studying outbreaks is to identify fine detail, down to individual DNA changes, to understand how the spread has happened. New sequencing technologies make visible the previously invisible changes in many samples.

"The powerful new sequencing methods can examine macroevolution - how much do distantly collected isolates differ? - but they can also look at microevolution - how much variation occurs within an outbreak? This variation will be important in tracking the spread of these bacteria between hospitals and patients."

Professor Julian Parkhill, senior author on the study from the Wellcome Trust Sanger Institute

To investigate the detailed picture the team sequenced the genomes of 25 isolates collected between 1985 and 2007. The data shows that genes transferred between organisms have been a powerful force in shaping the genome of Cdiff. Mobile genetic elements in bacteria often carry antibiotic-resistance genes: transfer of these elements in the Cdiff lineage has occurred repeatedly in different places at different times. Many of the genes Cdiff acquires in this way may have made it the threat it is today.

As well as the image of transfer of genes between bacteria on mobile elements, the report also looks at more familiar single-letter differences - SNPs in the genomes. Large clusters of SNPs jump out when genomes were compared with each other, highlighting regions that have undergone more than simple, single-letter changes, but result because ancestral Cdiff have exchanged regions of as much as 300,000 letters of code with more distantly related organisms from the same species, showing that Cdiff can exchange core genes across large evolutionary distances.

"We also found 12 genes under selection in the Cdiff genome: these might be candidates for those important to the infection process. Identifying genes that are selected for variation may point us to which genes are interacting directly with the host, possibly those seen by the immune system."

Miao He, first author from the Wellcome Trust Sanger Institute

Cdiff has, over recent years, risen up the healthcare agenda and the infection is now the leading cause of antibiotic-associated diarrhoeal disease - causing illness in more than 35,000 people in England's hospitals last year. However, the genetic basis for Cdiff's emergence has been elusive: this work begins that archaeology.

"Disease-associated variants have emerged, and we would expect them to continue to emerge, from different lineages, in different places. This hasn't simply happened once."

"We show how Cdiff is still evolving and expect there is more to come."

Professor Julian Parkhill, Sanger Institute

Notes to Editors
  • Evolutionary dynamics of Clostridium difficile over short and long time scales.

    He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF et al.

    Proceedings of the National Academy of Sciences of the United States of America 2010;107;16;7527-32


This work was funded by the Wellcome Trust.

Participating Centres
  • Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom
  • Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7748 379849

Recent News

Appointments and changes to the Genome Research Limited Board
At the GRL Board meeting on 2 December 2019, David Willetts announced his intention to step down as Chair because of his extensive commitments across the academic and science sectors. Wellcome's Director, Jeremy Farrar, will take over the Chair of GRL Board from 1 January 2020.
Researchers identify new possibilities for the treatment of inflammatory bowel disease
Two molecular pathways found to be integral to maintaining balance in the digestive system
Root of childhood kidney cancer discovered
Pre-cancerous signatures found in healthy tissue point the way towards new treatment options